In 2007, he was appointed vice president, General Manager in France. Because Amgen is so involved in every aspect of each disease we make medicines for, we are very aware of the challenges patients with these conditions face. Black and white images (left to right) (top to bottom): A row of roller bottles in Building 6. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Amgen Education - Therapeutic Area Page. Amgen’s scientific success has been rooted in a unique “triple threat” capability that includes world-class human genetics, a deep understanding of disease biology, and the molecular engineering expertise needed to design the right drug for the right target. Amgen Foundation. Diversity and Inclusion. Join to Connect. Our Medicines; Value Solutions; Care Solutions; Amgen Biosimilars ; Medical information; Responsibility. The sPGA is a six-point scale that measures psoriasis severity based Vice President and Therapeutic Area Head at Amgen Oncology Greg received his A.B. A … Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Global CMC Therapeutic Area Head, General Medicine at Amgen Greater Los Angeles Area 500+ connections. We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. The firm is a venture capital arm of Amgen Inc. specializing in direct investments in early stage, seed/startup, growth capital, later stage, and emerging companies. USA. Deep Experience Worldwide Biologics Leader Therapeutic Area Heritage Expertise . Our product portfolio encompasses the following therapeutic areas: oncology, kidney diseases, hematology, bone diseases and cardiovascular diseases. Amgen Business Development. At Amgen, we are relentless in applying the highest ethical standards to everything we do. Environment. Amgen's pipeline of … Amgen subsidiary deCODE Genetics, a global leader in human genetics, is a powerful differentiator, greatly improving how we identify and validate human disease targets. CARDIOVASCULAR; ONCOLOGY/HAEMATOLOGY; NEPHROLOGY; BONE; BIOSIMILARS; UPCOMING (0) COMPLETED (4) OTHER (0) ALL (4) Kidney Week 2019: expert insights on CKD-MBD and beyond On … Amgen’s scientific success has been rooted in a unique “triple threat” capability that includes world-class human genetics, a deep understanding of disease biology, and the molecular engineering expertise needed to design the right drug for the right target. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Amgen's product pipeline will change over time as molecules move through the drug development process, including progressing through clinical phases to licensure and market returning to strategic partners, being outlicensed, or failing in clinical trials to demonstrate efficacy, safety or to deliver a commercially viable product, due to the nature of the development process. We are now applying that experience to … However, if you like to, you can change your cookie settings at any time. Cardiology . PRODUCTS We go well beyond the development of innovative medicines and preventive therapies. Our product portfolio encompasses the following therapeutic areas: oncology, kidney diseases, hematology, bone diseases, cardiovascular diseases and inflammatory diseases. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A … We use cookies to give you the best experience on our website. … CLEAR X. Amgen is committed to leveraging modern biotechnology in developing high-quality biologic and biosimilar drugs across oncology and immunology. Adaptive Extends Immune Medicine Platform to Discover Therapeutic Antibodies From Recovered COVID-19 Patients Amgen Will Leverage Genetics, Immunology, Antibody Engineering and Manufacturing Capabilities Companies Will Begin Work Immediately. Search this site. Events Catalogue. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Across the therapeutic areas of clinical research, we analyze numerous biomarkers, and are always adding new validated methods to our panels that cover preclinical and clinical matrices. Supplier Sustainability . Events Catalogue. Global CMC Therapeutic Area Head, General Medicine at Amgen Greater Los Angeles Area 500+ connections. Nonetheless, the best could be yet to come.